Prognostic Role of miR-221 and miR-222 Expression in Cancer Patients: A Systematic Review and Meta-Analysis.

导出 OA

翻译打印收藏纠错

第一作者： Gloria,Ravegnini

第一单位： Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.

作者： Gloria,Ravegnini ^[1] ; Sarah,Cargnin ^[2] ; Giulia,Sammarini ^[1] ; Federica,Zanotti ^[1] ; Justo Lorenzo,Bermejo ^[3] ; Patrizia,Hrelia ^[1] ; Salvatore,Terrazzino ^[2] ; Sabrina,Angelini ^[4]

作者单位： Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy. ^[1] Department of Pharmaceutical Sciences and Interdepartmental Research Center of Pharmacogenetics and Pharmacogenomics (CRIFF), University of Piemonte Orientale, 28100 Novara, Italy. ^[2] Institute of Medical Biometry and Informatics, University of Heidelberg, 69120 Heidelberg, Germany. ^[3] Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy. s.angelini@unibo.it. ^[4]

关键词 cancer miR-221 miR-222 overall survival progression-free survival

DOI 10.3390/cancers11070970

PMID 31336701

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交